Model
Edge
Five Prime Therapeutics, Inc.
0001329049
Filing Type
4
Filing Date
3/1/2021
Updated
3/2/21, 5:00 AM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership